Biogen's multiple sclerosis drug, Plegridy receives European marketing approval - PharmaBiz, 3 days ago
Biogen Idec receives marketing authorization from EC for multiple sclerosis drug - News-Medical.Net, 3 days ago
A cell replacement therapy that can treat multiple sclerosis by using a patient's own cells is close to becoming a reality, researchers at The New York Stem Cell Foundation (NYSCF) Research Institute reveal. For the first time, NYSCF scientists ...MedIndia, 1 day ago Cell therapy for multiple sclerosis patients: Closer than ever? Science Daily, 1 day ago NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients Bio-Medicine, 3 days ago Scientists one step closer to creating viable cell replacement therapy for multiple sclerosis patients News-Medical.Net, 3 days ago
Alkermes plc, a biopharmaceutical company, has initiated a Phase I clinical study of ALKS 8700, a novel monomethyl fumarate, or MMF, molecule in development for the treatment of multiple sclerosis. The randomized, double-blind study will evaluate ...Individual.com, 3 days ago Reports Summarize Multiple Sclerosis Study Results from Novartis (Characteristics influencing therapy switch behavior after suboptimal response to... 4 Traders, 4 days ago Alkermes Starts Phase I Study Of Potential MS Treatment Bioresearch Online, 6 days ago Alkermes Announces Initiation of Phase 1 Clinical Study of ALKS 8700 for Treatment of Multiple Sclerosis 4 Traders, 4 days ago
Ireland-based biopharmaceutical firm Alkermes has started a Phase I clinical trial of ALKS 8700, a novel monomethyl fumarate (MMF) molecule being developed for the treatment of multiple sclerosis (MS). The trial will assess the safety, tolerability ...Pharmaceutical Business Review, 1 week ago Alkermes Begins Phase 1 Study Of ALKS 8700 For Treatment Of Multiple Sclerosis RTTNews.com, 1 week ago
Scientists have found that a drug used to treat multiple sclerosis may pave the way for a pill that can erase bad memories. Researchers have found that mice given fingolimod, a drug approved by the US Food and Drug Administration for treatment of multiple ...Business Standard, 2 months ago Pill to wipe out bad memories? Asian Age, 2 months ago
Mice severely disabled by a condition that was similar to multiple sclerosis (MS) were able to walk less than two weeks following treatment with human neural stem cells. In striking contrast to active, healthy mice, those with an MS-like condition must be fed ...Business Standard, 2 months ago Human Stem Cell Treatment can Help Mice With MS-Like Condition Walk Again Med India, 2 months ago
Researchers from General Hospital Report New Studies and Findings in the Area of Multiple Sclerosis (Utilization of physical rehabilitation among...
Researchers from General Hospital Report New Studies and Findings in the Area of Multiple Sclerosis (Utilization of physical rehabilitation among people with multiple sclerosis) By a News Reporter-Staff News Editor at Health & Medicine Week -- ...4 Traders, 4 days ago Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted OSIX News, 6 days ago
SOUTH BURLINGTON, Vt. - There are encouraging signs in multiple sclerosis research coming from a preliminary trial occurring at Fletcher Allen and UVM and 17 other centers around theBig News Network, 1 week ago
A young Adelaide mum heading to Russia for stem cell treatment for multiple sclerosis says the potentially lifesaving procedure is desperately needed in Australia. Megan Roberts reports. Share: Up Next Sorry, we can't show this content as your ...West Australian, 1 week ago
A woman with multiple sclerosis say she has been the victim of a postcode lottery after being refused a drug - available in other parts of the country - which could significantly reduce her pain. Yvette Hodges has the support of her neurologist and ...ITV.com, 7 hours ago Crowe Welcomes 'Cannabis Based Drug' for Multiple Sclerosis Sufferers Sinn Fein, 1 week ago
on your WebpageAdd Widget >Get your members hooked!